Annual Convention 2022 – Registration now open

Jan 17, 2022

As you know, the NSFGA 2022 Annual Convention on January 26 has morphed from an in-person to a hybrid to a fully virtual event over the space of a few weeks. The Annual Convention Committee has worked hard to make this Convention a success and with the help of Jeff Wentzell (NSDA), it has become a reality. We would therefore warmly welcome you to register for the 2022 Annual Convention as there are many excellent speakers and sessions that are relevant and practical so you won’t want to miss them. Visit the event page to register for the Convention. On the event page you can check out the agenda, speakers and sessions in the event.

Pesticide points will be awarded under NS Environment course T2058 and is worth 2.5 points (0.5 pts in Labelling and 2.0 pts in Pest Management). Points are awarded to specific sessions listed in the agenda and tuning-in is mandatory to qualify for points.

We really look forward to having you join us on January 26th. If you have any problems with the registration, please don’t hesitate to contact me and, with Jeff’s help, we’ll get it sorted out.

Source : NSFGA

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.